2005
DOI: 10.1248/bpb.28.2068
|View full text |Cite
|
Sign up to set email alerts
|

Bcl-2 Up-Regulation and P-p53 Down-Regulation Account for the Low Sensitivity of Murine L929 Fibrosarcoma Cells to Oridonin-Induced Apoptosis

Abstract: Drug resistance has been a major limitation to chemotherapy. There are many mechanisms that contribute to such resistance. In our study, we subcloned oridonin-sensitive and low sensitive L929 cells and both types of cells grew at almost the same growth rate. The acquired low sensitivity to oridonin-induced apoptosis was associated with Bcl-2 up-regulation and down-regulation of p53 phosphorylation. The p38 inhibitor SB203580 decreased Bcl-2 expression in the low sensitive L929 cells and made the cells more sen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
10
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 28 publications
(11 citation statements)
references
References 23 publications
1
10
0
Order By: Relevance
“…When p38MAPK signaling was inhibited, GPC3 was not able to induce up-regulation of the pro-apoptotic molecules Bax and PUMA, nor could it reduce the levels of the anti-apoptotic Bcl-xL, Bcl-2 and XIAP. The role of p38MAPK pathway in the regulation of apoptotic molecules was previously reported by other authors [36,37], however, this is the first report that demonstrates that GPC3 induces an increase in apoptosis susceptibility of mammary tumor cells through p38MAPK signaling pathway activation and the consequent regulation of Bax, PUMA, Bcl-xL, Bcl-2 and XIAP expression.…”
Section: Discussionmentioning
confidence: 54%
“…When p38MAPK signaling was inhibited, GPC3 was not able to induce up-regulation of the pro-apoptotic molecules Bax and PUMA, nor could it reduce the levels of the anti-apoptotic Bcl-xL, Bcl-2 and XIAP. The role of p38MAPK pathway in the regulation of apoptotic molecules was previously reported by other authors [36,37], however, this is the first report that demonstrates that GPC3 induces an increase in apoptosis susceptibility of mammary tumor cells through p38MAPK signaling pathway activation and the consequent regulation of Bax, PUMA, Bcl-xL, Bcl-2 and XIAP expression.…”
Section: Discussionmentioning
confidence: 54%
“…According to our findings, MAPKs activities were profoundly affected by oridonin, ERK activity was inhibited while JNK and P38 kinase activities were provoked, which was consistent with previous data of our studies. [35][36][37][38] However, when autophagy was blocked by 3-MA, both inhibition of ERK and activation of JNK and P38 kinase were reversed, suggesting that oridonin-induced autophagy exerted its synergic effect on apoptosis through MAPKs pathway.…”
Section: )mentioning
confidence: 99%
“…Oridonin causes apoptosis of cancer cells by inhibiting the activation of NF-κβ, signal transducer and activator of transcription 3 and protein kinase B (Akt) [11] . Oridonin also downregulates the expression of various genes that NF-κβ regulates, including Bcl-2, cyclooxygenase-2 (COX-2), cyclinD1, and adhesion molecules [12] . The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays an important role in various cellular processes including cell growth, survival, and motility [13] .…”
Section: Introductionmentioning
confidence: 99%